Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma — Manuela F. Azzola (2003) | RDL Network
Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma
Article 2003 en
Authors
MA
Manuela F. Azzola
HS
Helen M. Shaw
JT
John F. Thompson
Abstract
1 min read
TMR is an important independent predictor of survival for melanoma patients. If confirmed by studies from other centers, it has the potential to further improve the accuracy of melanoma staging, as well as to define more rigidly the risk categories for patients entering clinical trials.
Serigne Lo, Mary‐Ann El Sharouni, Karijn P.M. Suijkerbuijk, Tasnia Ahmed, Witkamp Arjen, Anne Ε. Cust, V. Sigurdsson, P. J. van Diest, Richard A Scolyer, Carla H. van Gils, John F. Thompson
Kimberley L. Kaufman, Swetlana Mactier, Nicola J. Armstrong, Duthika M. Mallawaaratchy, Scott N. Byrne, Lauren E. Haydu, Valerie Jakrot, John F. Thompson, Graham J. Mann, Richard A Scolyer, Richard I. Christopherson
Discussion(0)
No comments yet. Be the first to comment.